Coherus BioSciences: Q3 Earnings Snapshot
In this article:
REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Coherus BioSciences Inc. (CHRS) on Monday reported a loss of $39.6 million in its third quarter.
On a per-share basis, the Redwood City, California-based company said it had a loss of 41 cents. Losses, adjusted for stock option expense and amortization costs, were 27 cents per share.
The drug developer posted revenue of $74.6 million in the period, falling short of Street forecasts. Three analysts surveyed by Zacks expected $80.1 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CHRS at https://www.zacks.com/ap/CHRS
